Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: JAMA. 2011 Apr 11;305(15):1545–1552. doi: 10.1001/jama.2011.468

Table 2.

Mortality Associated With Cystatin C, Estimated Glomerular Filtration Rate, and Albuminuria

No. of Patients Total No. of Deaths HR (95% CI)
Adjusted Model 1a Adjusted Model 2b
Estimated GFR Creatinine ≥60 mL/min/1.73 m2
No CKD all 19 876 863 1 [Reference] 1 [Reference]

CKD defined by biomarker measuresc
 ACR alone 2485 241 1.9 (1.6–2.2) 1.7 (1.4–1.9)

 Cystatin C alone 963 173 2.5 (2.1–3.0) 2.2 (1.9–2.7)

 ACR + Cystatin C 415 105 3.9 (3.1–4.7) 3.0 (2.4–3.7)

Estimated GFR Creatinine <60 mL/min/1.73 m2
CKD defined by biomarker measuresc
 Creatinine alone 701 32 1 [Reference] 1 [Reference]

 Creatine + ACR 148 27 3.7 (2.2–6.2) 3.3 (2.0–5.6)

 Creatinine + Cystatin C 1172 223 3.5 (2.4–5.1) 3.2 (2.2–4.7)

 All biomarkers 883 276 6.6 (4.6–9.6) 5.6 (3.9–8.2)

Abbreviation: ACR, albumin-to-creatinine ratio; CI, confidence; CKD, chronic kidney disease; GFR, glomerular filtration rate; HR, hazard ratio.

a

Model 1 adjusts for age, race, sex, income, and educational attainment.

b

Model 2 adjusts for the above plus hypertension, diabetes, prevalent cardiovascular disease, smoking status, and body mass index.

c

See “Methods” section for definitions of biomarker measures.